+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Acute Hemodynamic Effect Of Sildenafil In Comparison With Inhaled Nitric Oxide In Patients Receiving Bosentan Therapy For Pulmonary Arterial Hypertension



Acute Hemodynamic Effect Of Sildenafil In Comparison With Inhaled Nitric Oxide In Patients Receiving Bosentan Therapy For Pulmonary Arterial Hypertension



Chest 132(4): 488a-1-488a-2




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067924346

Download citation: RISBibTeXText

DOI: 10.1378/chest.132.4_meetingabstracts.488a


Related references

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: Comparison with inhaled nitric oxide. Circulation 105(20): 2398-2403, 2002

Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study. Journal of Clinical Pharmacology 49(11): 1343-1352, 2009

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension. Pulmonary Circulation 3(1): 68-73, 2013

Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension. Internal Medicine 51(20): 2857-2862, 2012

Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 127(5): 1647-1653, 2005

Hemodynamic Effects of First-Line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension. Chest Journal 144(4): 868a-868b, 2013

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. American Journal of Cardiology 90(6): 677-680, 2002

Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan. International Heart Journal 52(4): 233-239, 2011

Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clinic Proceedings 78(10): 1207-1213, 2003

Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil. Clinical Respiratory Journal 3(4): 207-213, 2009

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. Journal of the American College of Cardiology 35(1): 176-182, 2000

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. European Respiratory Journal 46(2): 405-413, 2015

Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation 94(3): 477-482, 1996

Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controller. Lupus 16(11): 901-903, 2007

Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Critical Care 5(6): 355-361, 2001